NCT05285709

Brief Summary

Surgical treatment of hip fracture may be complicated by acute kidney injury. The aim of this study is to investigate whether the investigators can find a better biomarker than creatinine to recognize this problem at an earlier stage.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2022

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 21, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

March 15, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 18, 2022

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2023

Completed
Last Updated

April 5, 2022

Status Verified

April 1, 2022

Enrollment Period

1.6 years

First QC Date

January 21, 2022

Last Update Submit

April 4, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Any stage of acute kidney injury as defined by Kidney Diseases Improving Global Outcome

    Concentration of novel biomarkers, its change and change of renal resistive index considering different stages of acute kidney injury

    120 hours

Secondary Outcomes (3)

  • Kidney perfusion evaluated by Renal Resistive Index (RRI)

    48 hours

  • Analysis of proenkephalin concentration

    24 hours

  • Kidney dysfunction and mortality

    30 days

Interventions

BiomarkerDIAGNOSTIC_TEST

blood and urine sampling before and after surgery (1-admission to operating ward, 2-leaving operation ward, 1st day postop, 2nd day postop, 5th day postop, or the day patient leaves hospital, whichever is first)

RRI measurementDIAGNOSTIC_TEST

patients able to cooperate will have renal resistive index measured before and after surgery (admission to operating ward, leaving operating ward)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

all patients able to provide informed consent, who do not have diagnosed end stage renal disease undergoing surgical treatment of hip fracture (either joint alloplasty or internal fixation)

You may qualify if:

  • age at least 18 years
  • be able to provide informed consent

You may not qualify if:

  • end stage renal disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Gruca Orthopaedic and Trauma Teaching Hospital

Otwock, Masovian Voivodeship, 05-400, Poland

RECRUITING

I Department of Anesthesiology and Intensive Care Warsaw Medical University

Warsaw, Masovian Voivodeship, 02-005, Poland

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

urine and plasma from centrifuged whole blood after partial analysis of biomarkers

MeSH Terms

Conditions

Hip FracturesAcute Kidney Injury

Interventions

Environmental Biomarkers

Condition Hierarchy (Ancestors)

Femoral FracturesFractures, BoneWounds and InjuriesHip InjuriesLeg InjuriesRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

BiomarkersBiological FactorsBiological PhenomenaEnvironmental MonitoringEnvironmental ExposureEnvironmental PollutionPublic HealthEnvironment and Public Health

Central Study Contacts

Przemysław Bolewski

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 21, 2022

First Posted

March 18, 2022

Study Start

March 15, 2022

Primary Completion

November 1, 2023

Study Completion

November 1, 2023

Last Updated

April 5, 2022

Record last verified: 2022-04

Locations